908 Devices stock
MASSNASDAQ908 Devices Inc., HealthcareISIN US65443P1021
43Score 43 out of 100, Weak
Price and trend
65 / 100
Price history
+66% in one yearThe chart shows daily closes over 6 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Above the 200-day line: the price is 15% above it.
Since May 2026 the 50-day line has been above the 200-day line; the trend has turned up.
Normal: the price is neither overheated nor sold off (RSI 41).
The price is 24% below its 52-week high. Largest decline in 6 years: 97% (February 2021 to December 2024).
Chart figures for advanced users
- SMA 50$11.17
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$8.55
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)41
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDbelow the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$5.09
- The lowest closing price of the last twelve months.
- Resistance$12.87
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- 908 Devices Inc. belongs to the Medical (Specialties) industry (United States) and, with a market value of $407.09M, is number 12 of 14 companies in its industry on MEQIRI.
- For fiscal 2026, analysts expect on average revenue of $69.17M (up 23.1%) and adjusted earnings per share of −$0.92.
- MEQIRI Score 43 out of 100 (Weak): rank 493 of 702 in Healthcare, median 53.
Show more
- Our model puts fair value at $5.27, with the price 86% above it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- Growing faster than its industryRevenue up 21.1% a year since 2020, Medical (Specialties) median 12.9%.Growth 57
- More cash than debtCash $99.12M, financial debt $5.05M.Stability 70
Weaknesses
- DilutionShare count up 30% since 2021.Capital allocation 18
- Loss-makingLoss of $24.15M over the last 12 months.Fundamentals 17
- Volatile share priceVolatility 63% a year over the last 12 months.
Its standout strengths are momentum and stability, while capital allocation and fundamentals hold the score back.
Daily figure as of 13 Nov 2026
How the score is calculatedScore overview
Fundamental quality fluctuates.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk high
How well MEQIRI warnsOne of the 30% with the highest crash risk among smaller stocks.
From 2016 to 2025, 36 in 100 such stocks fell 30% or more within a year, against a group average of 23 in 100.
What drives the risk
- weak fundamentals
- high price swings
Valuation
Valuation signal
Modestly overvaluedIn our model the price counts as cheap below $3.51 and expensive above $10.54 (uncertainty very high, based on the price swings of the past year).
Calculated with a cost of equity of 8.8%. At 9.8% the fair value would be $4.21, at 7.8% it would be $6.88.
Valuation metrics
From the cash-flow model alone; without earnings there is no industry value.
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the quarter to 30 Sep 2026, revenue rose 35.3% on the same quarter a year earlier. Up to 2024 the bars include businesses that were later spun off or sold. On a comparable basis, as restated in the SEC annual reports, revenue grew 21.1% a year.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2025: gross 48%, operating −43%, net not measured.
Debt & balance sheet
latest quarterDebt is low; no interest coverage is reported.
Earnings
- Next earnings
- 2 Mar 2027in 109 days
- Last reported
- 10 Nov 2026EPS reported −$0.11 (expected −$0.15)above expectations
Analyst estimates
Earnings estimates have barely changed since 15 Oct 2026.
- Earnings per share
- −$0.920.0%
- Revenue
- $69.17M0.0%
- Earnings per share
- −$0.460.0%
- Revenue
- $82.54M0.0%
MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
Company outlook raised
Share price after the results: +13.9%2026 revenue guidance raised at the low end to $68 million to $70 million (up 21% to 25%), now excluding the AVCAD program.
“Looking ahead in 2026, we have raised the low end of our range and now expect revenue to be $68 million to $70 million, representing growth of 21% to 25% over full year 2025.”The outlook is not part of the score and not a recommendation to buy or sell.
From the earnings call on 11 Aug 2026 (fiscal Q2 2026), read by AI.
Insiders
Open-market purchases and sales by executives, board members and major holders
No open-market purchases in the last 6 months. 5 insiders sold, $8.44M in total.
Sales say less than purchases: many insiders sell on a fixed plan, for taxes or to diversify.
- Brown Christopher D.Sale
4 Nov 2026, Board
- Shares
- 30,000
- Price
- $10.95
- Value
- $328,500
- Brown Christopher D.Sale
7 Oct 2026, Board
- Shares
- 30,000
- Price
- $11.89
- Value
- $356,700
- Griffith Joseph H. IVSale
6 Oct 2026, Chief Financial Officer
- Shares
- 5,000
- Price
- $13.03
- Value
- $65,150
Show 37 more
- AWM Investment Company, Inc.Sale
29 Sept 2026, Major holder
- Shares
- 18,000
- Price
- $11.52
- Value
- $207,322
- AWM Investment Company, Inc.Sale
24 Sept 2026, Major holder
- Shares
- 24,000
- Price
- $11.36
- Value
- $272,626
- AWM Investment Company, Inc.Sale
23 Sept 2026, Major holder
- Shares
- 1,000
- Price
- $11.25
- Value
- $11,250
- Kenneweg JohnSale
17 Sept 2026, SVP, Sales & Product Marketing
- Shares
- 5,257
- Price
- $10.22
- Value
- $53,727
- Kenneweg JohnSale
16 Sept 2026, SVP, Sales & Product Marketing
- Shares
- 21,399
- Price
- $10.11
- Value
- $216,344
- Kenneweg JohnSale
15 Sept 2026, SVP, Sales & Product Marketing
- Shares
- 1,000
- Price
- $10.00
- Value
- $10,000
- Brown Christopher D.Sale
2 Sept 2026, Board
- Shares
- 30,000
- Price
- $10.58
- Value
- $317,400
- Griffith Joseph H. IVSale
25 Aug 2026, Chief Financial Officer
- Shares
- 11,459
- Price
- $10.95
- Value
- $125,476
- AWM Investment Company, Inc.Sale
21 Aug 2026, Major holder
- Shares
- 41,578
- Price
- $10.61
- Value
- $441,159
- AWM Investment Company, Inc.Sale
20 Aug 2026, Major holder
- Shares
- 8,422
- Price
- $10.52
- Value
- $88,638
- Knopp Kevin J.Sale
17 Aug 2026, President and CEO
- Shares
- 20,000
- Price
- $10.35
- Value
- $207,000
- Knopp Kevin J.Sale
13 Aug 2026, President and CEO
- Shares
- 7,622
- Price
- $10.06
- Value
- $76,677
- Knopp Kevin J.Sale
12 Aug 2026, President and CEO
- Shares
- 2,747
- Price
- $10.07
- Value
- $27,662
- Brown Christopher D.Sale
11 Aug 2026, Board
- Shares
- 8,358
- Price
- $9.23
- Value
- $77,144
- Knopp Kevin J.Sale
11 Aug 2026, President and CEO
- Shares
- 145,918
- Price
- $9.90
- Value
- $1.44M
- Brown Christopher D.Sale
10 Aug 2026, Board
- Shares
- 9,442
- Price
- $9.03
- Value
- $85,261
- Knopp Kevin J.Sale
10 Aug 2026, President and CEO
- Shares
- 348
- Price
- $9.06
- Value
- $3,153
- Brown Christopher D.Sale
5 Aug 2026, Board
- Shares
- 20,000
- Price
- $8.49
- Value
- $169,800
- AWM Investment Company, Inc.Sale
4 Aug 2026, Major holder
- Shares
- 50,000
- Price
- $8.36
- Value
- $417,765
- Knopp Kevin J.Sale
2 Jul 2026, President and CEO
- Shares
- 222
- Price
- $9.07
- Value
- $2,014
- Brown Christopher D.Sale
2 Jul 2026, Board
- Shares
- 2,200
- Price
- $9.02
- Value
- $19,844
- Brown Christopher D.Sale
30 Jun 2026, Board
- Shares
- 20,000
- Price
- $8.84
- Value
- $176,800
- Knopp Kevin J.Sale
26 Jun 2026, President and CEO
- Shares
- 2,798
- Price
- $9.09
- Value
- $25,434
- Knopp Kevin J.Sale
25 Jun 2026, President and CEO
- Shares
- 16,388
- Price
- $9.10
- Value
- $149,131
- Knopp Kevin J.Sale
24 Jun 2026, President and CEO
- Shares
- 40,535
- Price
- $9.14
- Value
- $370,490
- Brown Christopher D.Sale
23 Jun 2026, Board
- Shares
- 9,900
- Price
- $9.04
- Value
- $89,496
- Knopp Kevin J.Sale
23 Jun 2026, President and CEO
- Shares
- 3,422
- Price
- $9.06
- Value
- $31,003
- AWM Investment Company, Inc.Sale
23 Jun 2026, Major holder
- Shares
- 3,050
- Price
- $9.00
- Value
- $27,463
- AWM Investment Company, Inc.Sale
22 Jun 2026, Major holder
- Shares
- 4,668
- Price
- $8.99
- Value
- $41,965
- Brown Christopher D.Sale
4 Jun 2026, Board
- Shares
- 100
- Price
- $9.00
- Value
- $900
- AWM Investment Company, Inc.Sale
4 Jun 2026, Major holder
- Shares
- 39,782
- Price
- $8.97
- Value
- $356,856
- Brown Christopher D.Sale
3 Jun 2026, Board
- Shares
- 20,000
- Price
- $8.73
- Value
- $174,600
- AWM Investment Company, Inc.Sale
2 Jun 2026, Major holder
- Shares
- 2,500
- Price
- $8.95
- Value
- $22,375
- AWM Investment Company, Inc.Sale
28 May 2026, Major holder
- Shares
- 170,442
- Price
- $8.66
- Value
- $1.48M
- Brown Christopher D.Sale
28 May 2026, Board
- Shares
- 30,000
- Price
- $9.00
- Value
- $270,000
- Griffith Joseph H. IVSale
28 May 2026, Chief Financial Officer
- Shares
- 6,940
- Price
- $9.03
- Value
- $62,668
- AWM Investment Company, Inc.Sale
27 May 2026, Major holder
- Shares
- 16,500
- Price
- $8.25
- Value
- $136,166
Partial trades from one filing are shown in one row, with the average price.
Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.
What happened at 908 Devices
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
702 rated companies in Healthcare
- This company
- 43
- Sector median
- 53
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Medical (Specialties)
The next larger and next smaller companies by market value
- Medacta GroupMOVE.SW $2.6B58
- Eckert & ZieglerEUZ.DE $1.01B73
- Mesa LaboratoriesMLAB $759.89M58
- QuidelOrthoQDEL $728.67M30
- Mobia MedicalMOBI $443.1M45
- Shoulder InnovationsSI $441.04M49
- BrainsWayBWAY $402.04M59
- IVF Hartmann HoldingVBSN.SW $351.57M67
ETFs that hold 908 Devices
Held by 3 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| Avantis Global Small Cap Value UCITS ETFAVWS | 0.03% | 0.39% | €1.49B |
| Xtrackers Russell 2000 UCITS ETF 1CXRS2 | 0.01% | 0.30% | €2.22B |
| State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc)ZPRR | 0.01% | 0.30% | €4.28B |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 23 Oct 2026)
- Valuation signal Fairly valued since 11 Nov 2026, previously Overvalued
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.